Human Clinical Trials
We're actively engaged with the USA FDA on our Pre-Submission Investigational Device Exemption for RadioGel™. Once the completed application is finalized, and submited;
upon approval we're planning to prepapre to treat Thyroid Cancer.
Updates Contact